Skip to Content
Skip to Footer
en-us
italiano
Sign In
Istituto Superiore di Sanità
Follow us on
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
MENU
Istituto Superiore di Sanità
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
Search Results - Home
Search
Search
Asset Entries
Any Asset
Web Content Article
(1)
Time
Any Time
Past Hour
(0)
Past 24 Hours
(0)
Past Week
(0)
Past Month
(0)
Past Year
(0)
Custom Range…
From
To
Search
No results were found that matched the keywords:
gioco d'azzardo indagine
.
Search
Release N°44/2021 In the last 45 days, 88.7% of sequenced swabs tested positive for the Delta variant
Web Content Article
ISS, September 17th 2021 - According to the COVID-19 Integrated Surveillance System, in Italy in the last 45 days, 88.7% of sequenced swabs tested positive for the Delta variant (as against 88.1%...
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Special on COVID-19 » Varianti del virus
Comunicato Stampa N°09/2024 - RespiVirNet: in calo ma resta sostenuta l’incidenza delle sindromi simil-influenzali
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
Comunicato Stampa N°46/2023 - Sorveglianza RespiVirNet: sale l’incidenza delle sindromi simil-influenzali, prevalgono i Rhinovirus
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
Comunicato Stampa N°47/2023 - Sorveglianza RespiVirNet: stabile l’incidenza delle sindromi simil-influenzali, prevalgono ancora i Rhinovirus ma aumentano i campioni positivi a influenza
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
Cos'è il Fentanyl, oppiode sintetico cento volte più potente della morfina che non è la "droga degli zombie"
Web Content Article
This result comes from the Italian version of this content.
Sono in corso delle
indagini
per vedere se il fenomeno è circoscritto o diffuso.
Newsroom:
Press notes
Press releases
PRESS RELEASE no. 10/2022 - Long-COVID: The ISS has launched its surveillance project. Among the objectives is a map of the Surveillance Centres
Web Content Article
ISS, 9 February 2022 The aim of the CCM project is to monitor the long-term effects of the SARS-CoV2 infection in order to gather data about the infection and standardize the approach and clinical...
Newsroom:
Press notes
Press releases
Special on COVID-19
Special on COVID-19 » Long COVID
CS N°38/2020 - Ipermemoria: un ricordo per ogni giorno. Nel cervello di “chi non dimentica” svelato il meccanismo che ordina la memoria
Web Content Article
This result comes from the Italian version of this content.
ISS, 9 giugno 2020 Un nuovo studio italiano, pubblicato sulla rivista Cortex, rivela l'esistenza di un'area cerebrale che permette alle persone dotate di ipermemoria autobiografica di "datare" i...
Newsroom:
Press releases
Release N°46/2021 Long-term care facilities: COVID-19-related deaths nosedive thanks to vaccines Slight increase in cases in the summer months
Web Content Article
ISS, September 30th 2021
Newsroom:
Press releases
Special on COVID-19
Comunicato Stampa N°45/2023 - Sorveglianza RespiVirNet: sale l’incidenza delle sindromi simil-influenzali, prevalgono i Rhinovirus
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
CS N°55/2020 - COVID-19 e demenza, un paziente su 6, tra i deceduti, affetto da deficit cognitivo
Web Content Article
This result comes from the Italian version of this content.
ISS, 17 novembre 2020 - Proprio la demenza avrebbe ostacolato la diagnosi tempestiva dell'infezione da SARS-CoV-2 accelerando una nefasta evoluzione. Tracciato l'identikit fisico e clinico di...
Newsroom:
Press releases
Press notes
CS N°19/2021 - Covid: nelle RSA primi effetti del vaccino, in calo incidenza e decessi
Web Content Article
This result comes from the Italian version of this content.
Questi i dati principali emersi
dall’indagine
L’incidenza settimanale di COVID-19
Newsroom:
Press releases
Press notes
Comunicato Stampa N°44/2023 Sorveglianza RespiVirNet: sale l’incidenza delle sindromi simil-influenzali, prevalgono i Rhinovirus
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
Comunicato Stampa N°49/2023 - Sorveglianza RespiVirNet: in sensibile aumento l’incidenza delle sindromi simil-influenzali, influenza al 29,4%
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
Comunicato Stampa N°48/2023 - Sorveglianza RespiVirNet: sensibile aumento delle sindromi simil-influenzali, crescono i campioni positivi ad influenza
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
Comunicato Stampa N°1/2024 - Sorveglianza RespiVirNet: resta alta l’incidenza delle sindromi simil-influenzali; Palamara, “Ipotizzabile circolazione sostenuta anche nelle prossime settimane”
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
Comunicato Stampa N°06/2024 - RespiVirNet: in calo ma resta sostenuta l’incidenza delle sindromi simil-influenzali
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
CS N°10/2021 - ISS e UNICEF Italia insieme su COVID-19 e maternità: la separazione mamma-neonato è associata a sensazione di angoscia materna e a maggiori difficoltà nell’allattamento. Le prime evidenze dal COVID Mothers Study, uno studio internazionale multicentrico
Web Content Article
This result comes from the Italian version of this content.
Il campione era composto da 357 madri provenienti da 31 paesi, 129 delle quali erano madri di neonati di età ≤30 giorni
Newsroom:
Press releases
Comunicato Stampa N°04/2024 - RespiVirNet: in calo ma resta alta l’incidenza delle sindromi simil-influenzali
Web Content Article
This result comes from the Italian version of this content.
Le
indagini
virologiche sui campioni biologici raccolti vengono eseguite dai Laboratori
Newsroom:
Press notes
Press releases
CS N° 61/2020 - Pandemia e impatto sulla popolazione: quasi tutti hanno indossato la mascherina nei luoghi al chiuso e sui mezzi pubblici. Due persone su tre inoltre sono disponibili a vaccinarsi, soprattutto gli anziani
Web Content Article
This result comes from the Italian version of this content.
ISS, 22 dicembre 2020 - I primi risultati sulla percezione del rischio e sui comportamenti degli italiani nello scenario pandemico realizzati con il nuovo modulo Covid che integra, con 17 nuove...
coronavirus
Newsroom:
Press releases
Special on COVID-19
Press notes
Press Release N° 31/2021 Smoking: Smokers increased by 1.2 million during the pandemic. Negative contribution of e-cigarettes and heated tobacco products. 1 in 5 students used tobacco and nicotine products
Web Content Article
ISS, May 31th 2021
Newsroom:
Press releases
20 Entries
Per Page
4
Entries per Page
8
Entries per Page
20
Entries per Page
40
Entries per Page
60
Entries per Page
Showing 61 to 79 of 79 entries.
Previous Page
Page
1
Page
2
Page
3
Page
4
Next Page
Hidden